This chapter explores the transformation of education through technology, focusing on the shift from traditional to digital methods. Key innovations like artificial intelligence, virtual and augmented reality, learning management systems, and cloud computing have revolutionized personalized learning and accessibility. Historical developments, from early educational tools to MOOCs, highlight their role in expanding global reach. The chapter addresses challenges such as the digital divide, quality assurance, and teacher re-skilling, emphasizing the importance of policies in fostering inclusive education. Future directions include hybrid models, immersive learning experiences, and AI-driven systems, blending traditional and digital approaches to create dynamic, student-centered environments.
Alkaptonuria is believed to be a rare autosomal recessive disease caused by an imbalance in homogentisate 1,2 dioxygenase (HGD). HGA builds up in the body when the HGD enzyme isn't working correctly, despite the kidneys' ability to frequently remove it. The diagnosis of AKU may not occur until the ochronotic arthropathy manifests, which usually happens in adulthood. There is a paucity of information on the condition's early stages and infancy. The development of a dark color formation in urine, dried urine spot (DUS), immunofluorescence, Thioflavin T (Th-T) staining, Congo Red (CR) staining, and transmission electron microscopy (TEM) may all be used to detect this. Ascorbic acid, phenylalanine and tyrosine diet restrictions, and the only medication approved by the European Medicine Agency as the first disease-modifying treatment for individuals with AKU is nitisinone, which has demonstrated promise as an additional treatment for alkaptonuria.